TG-1031

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTG-1031

Drug Alias Namepox virus-MUC1-IL-2vaccina virus-MUC1-IL-2VV-MUC1-IL-2pTG-1031TG-1031

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionInterleukin-2 stimulantsMUC1 gene stimulants

TargetsMucin-1Interleukin-2

Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTransgene Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTransgene Sa

Active IndicationsN/A

Inactive IndicationsProstatic NeoplasmsBreast Neoplasms

ATC CodeN/A